RYGB with BPL length ≥100cm results in better outcomesRoux-en-Y gastric bypass (RYGB) with a biliopancreatic limb (BPL) length ≥100cm resulted in higher odds of achieving ≥ 25% total weight...
RYGB with BPL length ≥100cm results in better outcomesRoux-en-Y gastric bypass (RYGB) with a biliopancreatic limb (BPL) length ≥100cm resulted in higher odds of achieving ≥ 25% total weight...
RYGB with BPL length ≥100cm results in better outcomesRoux-en-Y gastric bypass (RYGB) with a biliopancreatic limb (BPL) length ≥100cm resulted in higher odds of achieving ≥ 25% total weight...
Risk of PPI use higher after LSG vs. LRYGBThe risk of initiating and continuing proton pump inhibitors (PPI) treatment was significantly higher after laparoscopic sleeve...
Journal Watch 24/7/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
BMI as a measure of obesity and how this influences perceptions and patient careIn two new papers published in Annals of Internal Medicine, social justice and obesity experts weigh in on the Body Mass Index (BMI) and...
Positive Phase 1 data shows potential of CK-0045 to improve cardiometabolic risk factorsCytoki Pharma has revealed positive data from a Phase 1 study evaluating the safety, tolerability and pharmacokinetics of CK-0045, its...
Study finds increase in GLP-1RA prescriptions to treat obesity but reduced for T2DMAn investigation led by researchers at Cedars-Sinai Medical Center and other institutions conducted a US-wide, population-based study to...
Innovent’s DREAMS-1 trial of mazdutide GLP-1R and GCGR dual agonist meets study endpointsInnovent Biologics’ Phase 3 clinical trial (DREAMS-1) of mazdutide a glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor...
Roche’s oral GLP-1 receptor agonist CT-996 has weight loss of -6.1% within four weeksRoche has reported positive topline results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational,...
Journal Watch 17/7/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
AI analysis finds huge public interest in GLP-1 drugs for weight loss and mental health benefitsUsing a large language models (LLMs) to analyse over 391,000 unique discussions related to glucagon-like peptide-1 (GLP-1) receptor...
SH2B1 gene mutation play an important role in regulating food intakeResearchers from the University of Michigan have identified where a gene called SH2B1 is acting inside the paraventricular hypothalamus...
Harnessing network of CNS proteins could increase effectiveness of GLP-1sA network of proteins found in the central nervous system could be harnessed to increase the effectiveness and reduce the side effects of...
Phenomix launches personalised obesity care genetic testing available to women in with Hello Alpha partnership
iHerb launches new GLP-1 support products designed to combat common side effects from rapid weight loss
WHO issues warning on falsified medicines as Lilly warns patients about counterfeit and compounded medicines